Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BGB-11417 Cause Covid-19? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Covid-19 have been filed in association with BGB-11417. This represents 4.1% of all adverse event reports for BGB-11417.

5
Reports of Covid-19 with BGB-11417
4.1%
of all BGB-11417 reports
0
Deaths
5
Hospitalizations

How Dangerous Is Covid-19 From BGB-11417?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Covid-19 Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BGB-11417. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does BGB-11417 Cause?

Febrile neutropenia (16) Death (10) Neutropenic sepsis (10) Acute myeloid leukaemia (9) Pneumonia (7) Off label use (6) Pyrexia (5) Sepsis (5)

What Other Drugs Cause Covid-19?

NIRMATRELVIR\RITONAVIR (22,066) OCRELIZUMAB (11,454) ADALIMUMAB (9,138) DUPILUMAB (6,986) RITUXIMAB (6,301) LENALIDOMIDE (6,223) TOFACITINIB (4,926) SECUKINUMAB (3,871) INFLIXIMAB (3,698) TACROLIMUS (3,201)

Which BGB-11417 Alternatives Have Lower Covid-19 Risk?

BGB-11417 vs BICALUTAMIDE BGB-11417 vs BICTEGRAVIR BGB-11417 vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BGB-11417 vs BIFIDOBACTERIUM LONGUM BGB-11417 vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS

Related Pages

BGB-11417 Full Profile All Covid-19 Reports All Drugs Causing Covid-19 BGB-11417 Demographics